Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update

—Total Company Revenues of $425.5 Million for the Second Quarter of 2026— —BRINSUPRI® (brensocatib) Revenues of $309.2 Million for the Second Quarter of 2026,...

Aug 6, 2026 - 14:00
 0  17
Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update
—Total Company Revenues of $425.5 Million for the Second Quarter of 2026— —BRINSUPRI® (brensocatib) Revenues of $309.2 Million for the Second Quarter of 2026,...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow